Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol by Ontaneda, D, Tallantyre, E, Raza, P, Planchon, S, Nakamura, K, Miller, D, Hersh, C, Craner, M, Bale, C, Chaudhry, B, Gunzler, D, Love, T, Gerry, S, Coles, A, Cohen, J, Evangelou, N

When should placebo surgery as a control in clinical trials be carried out? by George, A, Collett, C, Carr, A, Holm, S, Bale, C, Burton, S, Campbell, M, Coles, A, Gottlieb, G, Muir, K, Parroy, S, Price, J, Rice, A, Sinden, J, Stephenson, C, Wartolowska, K, Whittall, H

Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) t... by Ontaneda, D, Tallantyre, E, Nakamura, K, Planchon, S, Miller, D, Hersh, C, Chaudhry, B, Bale, C, Alvarez, E, Chataway, J, Craner, M, Freeman, L, Frost, N, Goldman, M, Hobart, J, Hunt, D, Hutton, G, Hyland, M, Joseph, F, Lily, O, Moses, H, Nicholas, J, Nicholas, R, Overell, J, Pearson, O, Pomeroy, I, Smith, A, Zabeti, A, Gerry, S, Gunzler, D, Coles, A, LaRocca, N, Gray, E, Cohen, J, Evangelou, N